SEO report of cutaneousmalignancyeducation.info

Redirected to www.personalizedmedonc.com/conference-correspondents/

Conference Correspondents | Personalized Medicine in Oncology

www.personalizedmedonc.com/conference-correspondents/

Error! The "meta description" is missing, the page has no summary description!


 Tasks

  • Avoid using deprecated HTML tags.

 SEO

URL

Domain : www.personalizedmedonc.com/conference-correspondents/

Character length : 53

Title
Conference Correspondents | Personalized Medicine in Oncology
Keywords (meta keywords)
Good! The website does not use “meta keywords”.
Open Graph Protocol

Error! The website does not use the OG (Open Graph) protocol.

Dublin Core
Dublin Core is not used
Underscores in the URLs
Good! No underscore (_) found in the URLs.
Search engine friendly URLs
Good! The website uses SEO friendly URLs.
Checking the robots.txt file
There is robots.txt file.
https://personalizedmedonc.com/robots.txt
User-agentDisallowed for the search engines
*
  • /wp-admin/


 Social

Social Engagement

No info found.

 Content

Doctype
HTML 5
Encoding
Perfect! The character encoding is set: UTF-8.
Language
We have found the language localisation: ”en”.
Title
Conference Correspondents | Personalized Medicine in Oncology

Character length : 61

Good! The title’s length is between 10 and 70 characters.
Text / HTML ratio
Ratio : 24%

Acceptable! The text / code ratio is between 15 and 25 percent.
Headings
H1H2H3H4H5H6
1001470
Heading structure in the source code
  • <H1> Conference Correspondents
  • <H5> Patient-Reported Health Status Is Improved by the Addition of Palbociclib to Fulvestrant Treatment
  • <H5> Exploring the Relationship Between Progression-Free Survival and Overall Survival in Breast Cancer Patients Treated with Fulvestrant or Anastrozole
  • <H5> Improved Sensitivity to Endocrine Therapy Following Treatment with Eribulin Mesylate
  • <H5> Conversion of Biomarkers Between Primary Breast Cancer Tumor and Relapse May Have Prognostic Value
  • <H5> Exploratory Biomarkers in MONARCH 1: A Phase 2 Study of Abemaciclib Monotherapy in HR+/HER2– Metastatic Breast Cancer
  • <H5> Next-Generation Sequencing Reveals Molecular Subtypes Beyond Those Defined by Hormone Receptor Expression
  • <H5> Claim Data Reveal Treatment and Toxicity Patterns Associated with Everolimus Use
  • <H5> Circulating Tumor Cell Counts May Have Prognostic Value in Determining First-Line Therapy in HR+/HER2– Metastatic Breast Cancer
  • <H5> Preliminary Safety and Efficacy of TAK-228 plus Exemestane or Fulvestrant in ER+/HER2– Metastatic Breast Cancer
  • <H5> Fulvestrant 500 mg Is Well-Tolerated and Efficacious in Women with Locally Advanced Breast Cancer
  • <H5> Phase 2 Trial Data on Metformin Do Not Support Further Investigation as a Breast Cancer Therapy
  • <H5> Preoperative Metabolic Profiles Are Prognostic for Breast Cancer Recurrence
  • <H5> First-Line Everolimus plus Letrozole in ER+/HER– Breast Cancer
  • <H5> Antitumor Activity of PM01183 in BRCA-Associated Metastatic Breast Cancer
  • <H5> Tumor Biomarker Analysis from the Phase 3 PALOMA-2 Trial
  • <H5> The FALCON Study: A Phase 3 Comparison of Fulvestrant and Anastrozole in ER+ Advanced Breast Cancer
  • <H5> Comparison of Sequential and Concomitant Adjuvant Trastuzumab Treatment in HER2+ Breast Cancer
  • <H5> Outcome Disparities by Prognostic Indicators in HR+ Breast Cancer
  • <H5> Prognostic Role for Derived Neutrophil-to-Lymphocyte Ratio in Early Breast Cancer
  • <H5> Interim Phase 2 Results on Abemaciclib in Women with HR+/HER2– Breast Cancer
  • <H5> Panitumumab in Wild-Type KRAS and RAS Metastatic Colorectal Cancer
  • <H5> BBI608/FOLFIRI ± Bevacizumab in Advanced Colorectal Cancer
  • <H5> NEO-102, an Anti-MUC5AC Monoclonal Antibody, in Chemotherapy-Refractory Metastatic Colorectal Cancer
  • <H5> STEAM—Sequential versus Concurrent FOLFOXIRI/Bevacizumab in Metastatic Colorectal Cancer
  • <H5> Avelumab in Advanced Gastric or Gastroesophageal Cancer
  • <H5> Nivolumab Monotherapy in Advanced Gastroesophageal or Gastric Cancer
  • <H5> Pembrolizumab in PD-L1+ Advanced Esophageal Carcinoma
  • <H5> The Role of the mTOR Pathway in Cancer Stem Cells in Esophageal Cancer
  • <H5> Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
  • <H5> Treating Gastric Cancer by Targeting Notch and wnt-Beta-Catenin Cancer Stem-Cell Pathways
  • <H5> First-Line Demcizumab/Gemcitabine ± Nab-Paclitaxel in Pancreatic Cancer
  • <H5> BBI608/Gemcitabine/Nab-Paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma
  • <H5> Tremelimumab plus TACE, RFA, or Cryoablation in Hepatocellular Carcinoma or Biliary Tract Carcinoma
  • <H5> Molecular Biomarker Stratification of Adjuvant Treatment for Pancreatic Adenocarcinoma
  • <H5> The Cancer Stem-Cell Inhibitor BBI608 plus Paclitaxel in Advanced Pancreatic Cancer
  • <H5> Special ASCO Edition
  • <H5> PMO Live 2015 – Highlights from Saturday, July 25
  • <H5> PMO Live 2015 – Highlights from Friday, July 24
  • <H5> PMO Live 2015 – Highlights from Thursday July 23
  • <H5> PMO Live 2015 – Highlights from Wednesday July 22
  • <H5> Conference Correspondents in Lung Cancer from the 2015 ASCO Annual Meeting
  • <H5> Highlights from the Academy of Oncology Nurse & Patient Navigator Regional Meeting
  • <H5> Show Reports from the 2015 Association for Value-Based Cancer Care Conference
  • <H5> Highlights from Day 2 of the Third Annual PMO Live Conference
  • <H5> Highlights from Day 1 of the Third Annual PMO Live Conference
  • <H5> Highlights from Day 2 of the Third Annual World Cutaneous Malignancies Congress Conference
  • <H5> Highlights from Day 1 of the Third Annual World Cutaneous Malignancies Congress Conference
  • <H4> linkedin Connect with us
Word cloud
  • cancer77
  • breast37
  • study31
  • annual30
  • patients25
  • pmo25
  • conference25
  • volume22
  • esmo22
  • advanced21
  • asco21
  • phase21
  • live21
  • inhibitor19
  • metastatic16
  • treatment16
  • receptor16
  • plus14
  • results14
  • cutaneous13
  • malignancies13
  • congress13
  • fulvestrant12
  • care11
  • world11
  • biomarkers11
  • therapy10
  • day10
  • women10
  • highlights9
  • prognostic9
  • epidermal9
  • growth9
  • factor9
  • pancreatic8
  • clinical8
  • human8
  • gastric8
  • efficacy8
  • colorectal8
  • meeting8
  • receptor–positive7
  • molecular7
  • hormone7
  • pathway7
  • oncology7
  • safety7
  • biomarker7
  • medicine7
  • stem-cell7
  • tumor7
  • estrogen7
  • trial6
  • adenocarcinoma6
  • data6
  • combination6
  • treated6
  • gastroesophageal6
  • therapies6
  • opened6
Keyword matrix
wordtitledescriptionsheading
cancer
breast
study
annual
patients
pmo
Two Word cloud
  • breast cancer17
  • pmo live13
  • patients with9
  • third annual9
  • live conference8
  • this study8
Three Word cloud
  • third annual world5
  • highlights from day4
  • global biomarkers consortium4
  • world cutaneous malignancies4
  • opened with a review3
  • advanced breast cancer3
404 Page
The website has a 404 error page.
Flash content
Good! The website does not have any flash contents.
Frame
Error! The website uses iFrame solutions. This type of contents are not indexed by Google.

 Readability

Flesch–Kincaid Grade Level
9.80
Flesch Reading Ease
39.00
Coleman Liau Index
12.00
Automated Readability Index (ARI)
7.90
Dale–Chall Readability
8.70
SMOG Index
11.60
Spache Readibility
5.00
Number of letters
17609
Number of words
3265
Number of sentences
418
Average words per sentences
8
Number of syllables
6173
Syllables in words
6074
Average syllables in words
1.89
Number of words in first three syllables
897
Percentage of word / syllables
27.47
Words not in Dale-Chall easy-word list
1709
Words not in Spache easy-word list
655

 Technologies

Deprecated HTML elements
Good! No deprecated HTML tags are detected.
Redirection (www / not www)
Good! The web address is accessible only in one version. The version without www is redirected to the version with www.
Deprecated HTML elements
Good! No deprecated HTML tags are detected.
Printability
Suggestion! Unfortunately, no printer-friendly CSS found.
Meta Tag (viewport tag, mobile devices)
Error! The meta tag named viewport is missing.

 Speed test

Server response time
The server response time is fast enough.
Table layout
Good! No nested tables found.
Render blocking resources
Good! No render blocking elements found!

 Speed test – Javascript

Javascript
Error! Too many javascript files found which slows down the page load on the website.
  • http://www.personalizedmedonc.com/wp-includes/js/jquery/jquery.js?ver=1.12.4
  • http://www.personalizedmedonc.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=1.4.1
  • http://www.personalizedmedonc.com/wp-content/themes/pmo/js/jquery.cycle2.min.js
  • http://www.personalizedmedonc.com/wp-content/themes/pmo/js/timecircles.js
  • http://www.personalizedmedonc.com/wp-content/themes/pmo/js/jquery.equalHeights.js
  • http://www.personalizedmedonc.com/wp-content/themes/pmo/js/theme.js
  • http://www.personalizedmedonc.com/wp-content/themes/pmo/js/jquery-cookie.js
  • http://www.personalizedmedonc.com/wp-includes/js/wp-embed.min.js?ver=4.7.4
  • http://www.personalizedmedonc.com/wp-content/plugins/gravityforms/js/jquery.json.min.js?ver=2.1.2
  • http://www.personalizedmedonc.com/wp-content/plugins/gravityforms/js/gravityforms.min.js?ver=2.1.2
  • http://www.personalizedmedonc.com/wp-content/plugins/gravityformspolls/js/gpoll.js?ver=3.1
File size of all javascript files combined
0.00
Javascript minifying
Great! The Javascript files are minified.

 Speed test – CSS

CSS
Error! Too many CSS files detected that slows down the page load.
  • http://www.personalizedmedonc.com/wp-content/themes/pmo/css/global.css
  • http://www.personalizedmedonc.com/wp-content/plugins/gravityforms/css/formreset.min.css?ver=2.1.2
  • http://www.personalizedmedonc.com/wp-content/plugins/gravityforms/css/formsmain.min.css?ver=2.1.2
  • http://www.personalizedmedonc.com/wp-content/plugins/gravityforms/css/readyclass.min.css?ver=2.1.2
  • http://www.personalizedmedonc.com/wp-content/plugins/gravityforms/css/browsers.min.css?ver=2.1.2
  • http://www.personalizedmedonc.com/wp-content/plugins/gravityformspolls/css/gpoll.css?ver=3.1
File size of all css files combined
0.00
CSS minifying
Great! The CSS elements are minified.

 Speed test – Compression

Uncompressed size of the of the HTML
0.00
Gzip compression
Your site uses compression.

 Speed test – Browser cache

Browser cache
The browser cache is set correctly for all elements.

 Speed test – Images

File size of all images combined
0.00
Image optimisation
All images are optimized.

 Links

We found a total of 149 different links.
Internal links: 123
External links: 26

External links:

Internal links:

Link text (anchor) Link strength

 Website security

IP
52.71.12.40
External hidden links
Good! No hidden external links found
Looking for eval()
Good! No eval(bas64_decode()) scripts are found
Checking for XSS vulnerability
No XSS vulnerability found
Email encryption
Good! We have not found any unencrypted email addresses.

 Sites on same ip

urologypracticemanagement.com

urologypracticemanagement.com

pharmacyretailclinicnews.net

pharmacyretailclinicnews.net

rheumatologypracticemanagement.com

rheumatologypracticemanagement.com

oncpracticemanagement.com

oncpracticemanagement.com

cutaneousmalignancyeducation.info

cutaneousmalignancyeducation.info

 Icons

Favicon
Good! The website uses favicon.

 Typos

utaneousmalignancyeducation.info, cxutaneousmalignancyeducation.info, xutaneousmalignancyeducation.info, csutaneousmalignancyeducation.info, sutaneousmalignancyeducation.info, cutaneousmalignancyeducation.info, utaneousmalignancyeducation.info, cdutaneousmalignancyeducation.info, dutaneousmalignancyeducation.info, cfutaneousmalignancyeducation.info, futaneousmalignancyeducation.info, cvutaneousmalignancyeducation.info, vutaneousmalignancyeducation.info, c utaneousmalignancyeducation.info, utaneousmalignancyeducation.info, ctaneousmalignancyeducation.info, cuytaneousmalignancyeducation.info, cytaneousmalignancyeducation.info, cuhtaneousmalignancyeducation.info, chtaneousmalignancyeducation.info, cujtaneousmalignancyeducation.info, cjtaneousmalignancyeducation.info, cuktaneousmalignancyeducation.info, cktaneousmalignancyeducation.info, cuitaneousmalignancyeducation.info, citaneousmalignancyeducation.info, cu7taneousmalignancyeducation.info, c7taneousmalignancyeducation.info, cu8taneousmalignancyeducation.info, c8taneousmalignancyeducation.info, cuaneousmalignancyeducation.info, cutraneousmalignancyeducation.info, curaneousmalignancyeducation.info, cutfaneousmalignancyeducation.info, cufaneousmalignancyeducation.info, cutganeousmalignancyeducation.info, cuganeousmalignancyeducation.info, cuthaneousmalignancyeducation.info, cuhaneousmalignancyeducation.info, cutyaneousmalignancyeducation.info, cuyaneousmalignancyeducation.info, cut5aneousmalignancyeducation.info, cu5aneousmalignancyeducation.info, cut6aneousmalignancyeducation.info, cu6aneousmalignancyeducation.info, cutneousmalignancyeducation.info, cutaqneousmalignancyeducation.info, cutqneousmalignancyeducation.info, cutawneousmalignancyeducation.info, cutwneousmalignancyeducation.info, cutazneousmalignancyeducation.info, cutzneousmalignancyeducation.info, cutaneousmalignancyeducation.info, cutneousmalignancyeducation.info, cutaxneousmalignancyeducation.info, cutxneousmalignancyeducation.info, cutasneousmalignancyeducation.info, cutsneousmalignancyeducation.info, cutaeousmalignancyeducation.info, cutanbeousmalignancyeducation.info, cutabeousmalignancyeducation.info, cutangeousmalignancyeducation.info, cutageousmalignancyeducation.info, cutanheousmalignancyeducation.info, cutaheousmalignancyeducation.info, cutanjeousmalignancyeducation.info, cutajeousmalignancyeducation.info, cutanmeousmalignancyeducation.info, cutameousmalignancyeducation.info, cutan eousmalignancyeducation.info, cuta eousmalignancyeducation.info, cutanousmalignancyeducation.info, cutanewousmalignancyeducation.info, cutanwousmalignancyeducation.info, cutanesousmalignancyeducation.info, cutansousmalignancyeducation.info, cutaneousmalignancyeducation.info, cutanousmalignancyeducation.info, cutanedousmalignancyeducation.info, cutandousmalignancyeducation.info, cutanefousmalignancyeducation.info, cutanfousmalignancyeducation.info, cutanerousmalignancyeducation.info, cutanrousmalignancyeducation.info, cutane3ousmalignancyeducation.info, cutan3ousmalignancyeducation.info, cutane4ousmalignancyeducation.info, cutan4ousmalignancyeducation.info, cutaneusmalignancyeducation.info, cutaneoiusmalignancyeducation.info, cutaneiusmalignancyeducation.info, cutaneokusmalignancyeducation.info, cutanekusmalignancyeducation.info, cutaneolusmalignancyeducation.info, cutanelusmalignancyeducation.info, cutaneousmalignancyeducation.info, cutaneusmalignancyeducation.info, cutaneopusmalignancyeducation.info, cutanepusmalignancyeducation.info, cutaneo9usmalignancyeducation.info, cutane9usmalignancyeducation.info, cutaneo0usmalignancyeducation.info, cutane0usmalignancyeducation.info, cutaneosmalignancyeducation.info, cutaneouysmalignancyeducation.info, cutaneoysmalignancyeducation.info, cutaneouhsmalignancyeducation.info, cutaneohsmalignancyeducation.info, cutaneoujsmalignancyeducation.info, cutaneojsmalignancyeducation.info, cutaneouksmalignancyeducation.info, cutaneoksmalignancyeducation.info, cutaneouismalignancyeducation.info, cutaneoismalignancyeducation.info, cutaneou7smalignancyeducation.info, cutaneo7smalignancyeducation.info, cutaneou8smalignancyeducation.info, cutaneo8smalignancyeducation.info, cutaneoumalignancyeducation.info, cutaneousqmalignancyeducation.info, cutaneouqmalignancyeducation.info, cutaneouswmalignancyeducation.info, cutaneouwmalignancyeducation.info, cutaneousemalignancyeducation.info, cutaneouemalignancyeducation.info, cutaneouszmalignancyeducation.info, cutaneouzmalignancyeducation.info, cutaneousxmalignancyeducation.info, cutaneouxmalignancyeducation.info, cutaneouscmalignancyeducation.info, cutaneoucmalignancyeducation.info, cutaneousalignancyeducation.info, cutaneousmnalignancyeducation.info, cutaneousnalignancyeducation.info, cutaneousmhalignancyeducation.info, cutaneoushalignancyeducation.info, cutaneousmalignancyeducation.info, cutaneousalignancyeducation.info, cutaneousmjalignancyeducation.info, cutaneousjalignancyeducation.info, cutaneousmkalignancyeducation.info, cutaneouskalignancyeducation.info, cutaneousmlalignancyeducation.info, cutaneouslalignancyeducation.info, cutaneousm alignancyeducation.info, cutaneous alignancyeducation.info, cutaneousmlignancyeducation.info, cutaneousmaqlignancyeducation.info, cutaneousmqlignancyeducation.info, cutaneousmawlignancyeducation.info, cutaneousmwlignancyeducation.info, cutaneousmazlignancyeducation.info, cutaneousmzlignancyeducation.info, cutaneousmalignancyeducation.info, cutaneousmlignancyeducation.info, cutaneousmaxlignancyeducation.info, cutaneousmxlignancyeducation.info, cutaneousmaslignancyeducation.info, cutaneousmslignancyeducation.info, cutaneousmaignancyeducation.info, cutaneousmalpignancyeducation.info, cutaneousmapignancyeducation.info, cutaneousmaloignancyeducation.info, cutaneousmaoignancyeducation.info, cutaneousmalignancyeducation.info, cutaneousmaignancyeducation.info, cutaneousmaliignancyeducation.info, cutaneousmaiignancyeducation.info, cutaneousmalkignancyeducation.info, cutaneousmakignancyeducation.info, cutaneousmalmignancyeducation.info, cutaneousmamignancyeducation.info, cutaneousmal.ignancyeducation.info, cutaneousma.ignancyeducation.info

More Sites

  • Title: 亿臣工贸-工业清洗专家,脱模剂,厂家直销
  • Description: 亿臣金属表面处理,亿臣工贸清洗剂,企业网站,亿臣工贸,工业清洗
  • Internet Protocol (IP) address:
  • Tech:
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Javascript
  • Title: 东莞文胜鼎电子科技有限公司
  • Description: 防伪、隐形防伪、美国技术、防伪元素、防伪激光标签、无标签防伪、防串货、隐形喷码防伪、隐形喷码防串货、糖果防伪串货、电线电缆防伪防串货、瓷砖防伪防串货、饮料防串货、凉茶防串货、化妆品防伪串货、出货管理、文胜鼎防伪、文胜鼎防串货。
  • Internet Protocol (IP) address:
  • Tech:
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Javascript
  • Title: EBD - European Business Directory
  • Description:
  • Internet Protocol (IP) address:
  • Tech:
    • Analytic
      • Google Analytics
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Javascript
      • Php (Hypertext Preprocessor)
  • Title: Healthy and Happy
  • Description:
  • Sites loading time: 1586
  • Internet Protocol (IP) address:
  • Javascript total size: 191.46KB
  • CSS total size: 174.53KB
  • Image total size: 453.31KB
  • Total size: 943.51KB
  • Tech:
    • CMS
      • Wordpress CMS
    • Analytic
      • WordPress Stats
    • Other
      • CSS (Cascading Style Sheets)
      • Gravatar
      • Html (HyperText Markup Language)
      • Html5
      • Javascript
      • jQuery
      • Php (Hypertext Preprocessor)
      • Pingback
      • SuperFish
  • Title: 井家上健三郎のえいぎょうほうしん日記
  • Description:
  • Internet Protocol (IP) address:
  • Tech:
    • CMS
      • Wordpress CMS
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Html5
      • Javascript
      • jQuery
      • Php (Hypertext Preprocessor)
      • Pingback
  • Title: The Robinson Foundation Inc.
  • Description: null
  • Internet Protocol (IP) address:
  • Tech:
    • Analytic
      • Google Analytics
    • Social
      • Add This
    • Other
      • CSS (Cascading Style Sheets)
      • Google Font API
      • Html (HyperText Markup Language)
      • Html5
      • Javascript
  • Title: choithramssupermarket.com
  • Description:
  • Internet Protocol (IP) address:
  • Tech:
    • Other
      • Html (HyperText Markup Language)
  • Title:
  • Description:
  • Internet Protocol (IP) address:
  • Tech:
    • Analytic
      • Google Analytics
    • Other
      • CSS (Cascading Style Sheets)
      • Google Font API
      • Html (HyperText Markup Language)
      • Html5
      • Javascript
      • SVG (Scalable Vector Graphics)
  • Title: Az endokrinológia területén jártas endokrinológus szakorvos várja
  • Description: A pajzsmirigy betegségek felismerése és a pajzsmirigy túlműködés kezelése az endokrinológia magánrendelés folyamán meg is történik.
  • Internet Protocol (IP) address:
  • Tech:
    • CMS
      • Wordpress CMS
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Html5
      • jQuery
      • Php (Hypertext Preprocessor)
      • Pingback
  • Title:
  • Description:
  • Internet Protocol (IP) address:
  • Tech:
    • Other
      • CSS (Cascading Style Sheets)
      • Html (HyperText Markup Language)
      • Html5
      • Javascript